Predictors of lack of glycemic control in persons with type 2 diabetes

Judy Z Louie1, Dov Shiffman1, Charles M Rowland1

  • 1Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA, 92675, USA.

PubMed

Insights

Many people with type 2 diabetes mellitus struggle to improve their HbA1c levels. Socioeconomic factors like race, income, and insurance significantly impact diabetes management and glycemic control.

Area of Science:

  • Endocrinology
  • Public Health
  • Health Disparities

Background:

  • Professional guidelines recommend HbA1c <7% for most with diabetes, and <8.5% for those with relaxed goals.
  • A significant number of individuals with type 2 diabetes mellitus (T2DM) do not achieve their target HbA1c.
  • This study investigates factors contributing to the lack of HbA1c improvement over three years.

Purpose of the Study:

  • To identify predictors of poor glycemic control in T2DM patients.
  • To explore the association between socioeconomic factors and the inability to improve HbA1c.
  • To inform targeted interventions for underserved populations with T2DM.

Main Methods:

  • Analysis of T2DM patients (2015-2020) with HbA1c >8.5% within three years.
  • Categorization into improved glycemic control (HbA1c ≤8.5%) or lack of improvement (HbA1c >8.5%).
  • Multivariate logistic regression to determine independent predictors of poor glycemic control.

Main Results:

  • Younger age, female gender, hypertension, Black race, low income, and non-Medicare insurance were associated with lack of HbA1c improvement.
  • Living in low-income areas showed a strong association with poorer glycemic control (OR 1.86).
  • Current smoking paradoxically correlated with HbA1c improvement, but this was not significant in subgroup analysis.

Conclusions:

  • Socioeconomic factors, including race, insurance type, and income level, are significantly linked to poor HbA1c control in T2DM.
  • Intervention strategies must address socioeconomic determinants to improve diabetes management, particularly in low-income communities.
  • Targeted public health initiatives are crucial for enhancing diabetes care in vulnerable populations.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940